AtriCure, Inc. Unrealized Gain (Loss) on Investments
AtriCure, Inc. (ATRC) reported Unrealized Gain (Loss) on Investments of -$261.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-02.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2025-02-14
- AtriCure, Inc. unrealized gain (loss) on investments for the quarter ending 2024-03-31 was -$261.00K.
- AtriCure, Inc. unrealized gain (loss) on investments for the quarter ending 2023-12-31 was $729.00K.
- AtriCure, Inc. unrealized gain (loss) on investments for the quarter ending 2023-09-30 was $701.00K.
- AtriCure, Inc. unrealized gain (loss) on investments for the quarter ending 2023-06-30 was $427.00K.
- AtriCure, Inc. unrealized gain (loss) on investments for fiscal 2023 was -$800.00K.
- AtriCure, Inc. unrealized gain (loss) on investments for fiscal 2022 was -$3.70M.
- AtriCure, Inc. unrealized gain (loss) on investments for fiscal 2021 was -$887.00K, a 1742.59% decline from fiscal 2020.
- AtriCure, Inc. unrealized gain (loss) on investments for fiscal 2020 was $54.00K, a 46.00% decline from fiscal 2019.
| Period end | Unrealized Gain (Loss) on Investments 3 month | Unrealized Gain (Loss) on Investments 6 month | Unrealized Gain (Loss) on Investments 9 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$261.00K 10-Q · filed 2024-05-02 | $468.00K derived: sum of 2 quarters · filed 2025-02-14 | $1.17M derived: sum of 3 quarters · filed 2025-02-14 | $1.60M derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-12-31 | $729.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $1.43M derived: sum of 2 quarters · filed 2025-02-14 | $1.86M derived: sum of 3 quarters · filed 2025-02-14 | -$800.00K 10-K · filed 2025-02-14 |
| 2023-09-30 | $701.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.13M derived: sum of 2 quarters · filed 2023-11-02 | -$1.53M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $427.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | -$2.23M 10-Q · filed 2023-07-26 | ||
| 2023-03-31 | -$2.66M 10-Q · filed 2023-05-03 | |||
| 2022-12-31 | -$3.70M 10-K · filed 2024-02-16 | |||
| 2021-12-31 | -$887.00K 10-K · filed 2023-02-22 | |||
| 2020-12-31 | $54.00K 10-K · filed 2022-02-17 | |||
| 2019-12-31 | $100.00K 10-K · filed 2021-02-26 | |||
| 2018-12-31 | -$37.00K 10-K · filed 2020-02-24 | |||
| 2017-12-31 | -$6.00K 10-K · filed 2019-03-01 | |||
| 2016-12-31 | -$21.00K 10-K · filed 2018-02-28 | |||
| 2015-12-31 | -$39.00K 10-K · filed 2017-03-08 | |||
| 2014-12-31 | -$54.00K 10-K · filed 2016-02-29 | |||
| 2013-12-31 | -$6.00K 10-K · filed 2015-03-02 | |||
| 2012-12-31 | $1.00K 10-K · filed 2014-03-11 | |||
| 2011-12-31 | $2.00K 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |